TLR3 and hepatocellular carcinoma: This pathway has been harnessed in preclinical studies showing that co-cultures with the TLR3 agonist Poly I: C can directly induce apoptosis in various cancer cell types, including breast, cervical, melanoma, colorectal, hepatocellular carcinoma, oral squamous cell carcinoma, and lung cancer [7, 55].